2026 House Bill 6020

Health: research; participation in ibogaine clinical trials; provide for.

A bill to amend 1978 PA 368, entitled “Public health code,” by amending section 7212 (MCL 333.7212), as amended by 2013 PA 268, and by adding sections 2222, 2222a, and 2222b.

Official record

AI Analysis – Experimental

Establishes a state-funded grant program and research fund to support FDA-overseen clinical trials of ibogaine for opioid and related disorders, amends Michigan law to allow regulated research and potential medical use of ibogaine, and appropriates $50 million from opioid settlement funds for these purposes.

Introduced in the House

May 21, 2026

Introduced by Rep. Jaime Greene (R-65) and 21 co-sponsors

Co-sponsored by Reps. Mike McFall (D-14), Joseph Pavlov (R-64), Mike Mueller (R-72), Mike Hoadley (R-99), Greg Markkanen (R-110), Jerry Neyer (R-92), David Martin (R-68), Donni Steele (R-54), Ron Robinson (R-58), Tom Kunse (R-100), Joey Andrews (D-38), Donavan McKinney (D-11), Kimberly Edwards (D-12), Morgan Foreman (D-33), Joe Tate (D-9), Timothy Beson (R-96), Doug Wozniak (R-59), Brad Paquette (R-37), Cameron Cavitt (R-106), Noah Arbit (D-20) and William Bruck (R-30)

Referred to the Committee on Families and Veterans

June 9, 2026

Reported without amendment

Referred to the Committee on Rules